CAS
RMD icon

Coppell Advisory Solutions’s ResMed RMD Stock Holding History

Coppell Advisory Solutions’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-185
Closed -$42.5K – 1517
2024
Q4 		$42.5K Buy
185
+175
+1,750% +$42.1K 0.01% 636
2024
Q3 		$2.39K Hold
10
– – ﹤0.01% 1411
2024
Q2 		$1.91K Buy
+10
New +$2.03K ﹤0.01% 1392

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Coppell Advisory Solutions's RMD Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of ResMed (RMD) in Q1 2025, closing a stake of 185 shares — an estimated $42.5K sold.

Coppell Advisory Solutions first reported a position in RMD in Q2 2024 and held it in 3 quarters. The position peaked at $42.5K in Q4 2024. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Coppell Advisory Solutions reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 185 ResMed shares in Q1 2025, an estimated $42.5K.
  • Coppell Advisory Solutions first reported a position in ResMed in Q2 2024 and held it in 3 quarters.
  • Coppell Advisory Solutions's ResMed position peaked at $42.5K in Q4 2024.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.